ASP Isotopes Inc. has entered into a Series Seed-1 Preferred Stock Purchase Agreement with Opeongo, Inc., a biotechnology company. Under the agreement, ASP Isotopes will purchase 4,356,918 shares of Opeongo's Series Seed-1 Preferred Stock at a price of $2.2952 per share. As part of the transaction, ASP Isotopes has been granted veto rights over certain major corporate actions of Opeongo and is entitled to elect and remove one director to Opeongo’s board. Additionally, ASP Isotopes and Opeongo have agreed to negotiate a supply agreement within thirty days, giving ASP Isotopes a right of first offer for the supply of medical isotopes for Opeongo’s pharmaceutical products. The investment also includes customary investor rights, such as participation in future equity offerings, right of first refusal, and co-sale rights.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ASP Isotopes Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-26-000555), on January 30, 2026, and is solely responsible for the information contained therein.
Comments